Overview:
Pharmaceuticals: Global Industry Almanac: Global Industry Almanac is an essential resource for top-level data and analysis covering the Pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis.
Scope of the Report
* Contains an executive summary and data on value, volume and segmentation
* Provides textual analysis of the industry's prospects, competitive landscape and profiles of the leading companies
* Incorporates in-depth five forces competitive environment analysis and scorecards
* Covers the Global, European and Asia-Pacific markets as well as individual chapters on Australia, Belgium, Brazil, Canada, China, Czech Republic, Denmark, France, Germany, Hungary, India, Italy, Japan, Mexico, Netherlands, Norway, Poland, Russia, Singapore, South Africa, South Korea, Spain, Sweden, United Kingdom and United States.
* Includes a five-year forecast of the industry
Highlights
The global pharmaceuticals market grew by 4.3% in 2010 to reach a value of $693 billion.
In 2015, the global pharmaceuticals market is forecast to have a value of $917.1 billion, an increase of 32.3% since 2010.
Other therapeutic purposes is the largest segment of the global pharmaceuticals market, accounting for 32% of the market's total value.
Americas accounts for 51.8% of the global pharmaceuticals market value.
Pfizer Inc. is the leading player in the global pharmaceuticals market, generating a 10% share of the market's value.
Why you should buy this report
* Spot future trends and developments
* Inform your business decisions
* Add weight to presentations and marketing materials
* Save time carrying out entry-level research
Market Definition
The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors). Any currency conversions used in the production of this report have been calculated at constant 2009 annual average exchange rates.
|
